Dnanexus

The page describes Trusted Research Environments for secure data analysis and collaboration, data protection, compliance, and insights.

Welcome to the repository for all things DNAnexus. Sort through case studies, webinars, white papers, and videos by their associated DNAnexus product and key topics.

The webinars cover migration from on-premises systems to the UKB-RAP cloud platform.

New Universal DeepVariant is one microservice compatible across multiple sequencing platforms and is designed to deliver more than 50x acceleration compared to CPU.

Automated workflow enhances genomics biomarker analysis, reduces risk, and accelerates project timelines.

Company appoints Pieter De Leenheer as Chief Technology Officer and Todd Oakland as Senior Vice President and General Manager of Biopharma Business Dx/Rx.

June 08, 2023. DNANexus company of the year for global precision medicine informatics industry.

The page lists open roles at the company.

The company comprises scientists, engineers, cloud experts, and compliance specialists focused on accelerating genomic research to advance scientific discovery and deliver better patient care.

DNAnexus built a cloud platform and global network for scientific collaboration and accelerated discovery.

The page describes precision health data as a way to drive scientific breakthroughs. DNAnexus helps hundreds of biomedical organizations accelerate scientific discovery.

DNAnexus is the leading bioinformatics company that facilitates secure access and utilization of biomedical data while supporting collaboration across internal and external teams.

This page provides important information about the identity, location and role of each Subprocessor.

DNAnexus Acceptable Use Policy (AUP): For subscribers and developers who use the DNAnexus Platform

MSA Acceptable Use Policy: For subscribers and developers who use the DNAnexus Platform.

TRE Acceptable Use Policy

DNAnexus Platform Application Agreement: For app developers who wish to license their app on the DNAnexus Platform.

DNAnexus expands its relationship with Veeva by integrating Veeva RIM with DNAnexus Trusted Regulatory Spaces, an effort aimed at advancing global regulatory collaboration. The announcement also includes comments from Thomas Laur and Marc Gabriel about the expanded relationship and integration.

Feb 2025 · BioSpaceNews article

DNAnexus strengthens its leadership team with the appointments of Nupura Kolwalkar as chief product officer and Bill Madigan as chief commercial officer. The company says the hires will drive ongoing product innovation and commercial growth.

Oct 2024 · Business Wire via FinancialContentNews article

GitHubRepository owner

DNAnexus appoints Thomas Laur as CEO and board member, effective September 11, 2023. He succeeds Richard Daly, who remains an advisor and board member.

Sep 2023 · ITDigestNews article